Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1971 1
1974 1
1976 1
1977 1
1979 1
1982 1
1984 1
1988 1
1989 1
1990 1
1991 1
1993 1
1995 1
1996 3
1998 2
1999 2
2002 1
2003 2
2004 4
2005 6
2006 2
2007 4
2008 2
2009 5
2010 3
2011 1
2012 1
2013 4
2014 6
2015 8
2016 3
2017 7
2018 8
2019 4
2020 12
2021 21
2022 22
2023 18
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Systemic lupus erythematosus and ocular involvement: an overview.
Dammacco R. Dammacco R. Clin Exp Med. 2018 May;18(2):135-149. doi: 10.1007/s10238-017-0479-9. Epub 2017 Dec 14. Clin Exp Med. 2018. PMID: 29243035 Review.
Purtscher-like retinopathy is likely ascribable to the formation of microemboli that results in retinal vascular occlusion and microvascular infarcts. Choroidal disease is characterized by monolateral or bilateral blurred vision. ...
Purtscher-like retinopathy is likely ascribable to the formation of microemboli that results in retinal vascular occlusion …
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Monés J, et al. Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15. Ophthalmology. 2021. PMID: 33207259 Free article. Clinical Trial.
MAIN OUTCOME MEASURES: Within this patient subset: incidence of IOI, signs and incidence of retinal vasculitis and/or retinal vascular occlusion, and visual acuity loss; time since first brolucizumab injection to IOI event onset; and frequency of visual acuit …
MAIN OUTCOME MEASURES: Within this patient subset: incidence of IOI, signs and incidence of retinal vasculitis and/or retinal vasc …
MYTHS AND TRUTHS OF THE ASSOCIATION OF RETINAL VASCULAR OCCLUSION WITH COVID-19.
Sharma A, Parachuri N, Kumar N, Romano MR, Parolini B, Ozdek S, Tawfik MA, Marashi A, Kuppermann BD, Nguyen QD. Sharma A, et al. Retina. 2022 Mar 1;42(3):413-416. doi: 10.1097/IAE.0000000000003371. Retina. 2022. PMID: 34907124 Free PMC article. Review.
PURPOSE: To critically review data published in the recent past to scrutinize a causal relationship between retinal vascular occlusion and COVID-19. METHOD: A comprehensive literature search was performed on Pubmed with the key words retinal vascula …
PURPOSE: To critically review data published in the recent past to scrutinize a causal relationship between retinal vascular …
Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.
Yeo S, Kim H, Lee J, Yi J, Chung YR. Yeo S, et al. Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1793-1808. doi: 10.1007/s00417-022-05953-7. Epub 2023 Jan 4. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36598554 Free PMC article. Review.
We reviewed and investigated studies on retinal vascular occlusions in patients diagnosed with COVID-19 and in those vaccinated for COVID-19. METHODS: Studies that reported retinal vascular occlusion in COVID-19 patients or in vaccinated people were identifie …
We reviewed and investigated studies on retinal vascular occlusions in patients diagnosed with COVID-19 and in those vaccinated for COVID-19 …
Acute Vision Loss.
Bagheri N, Mehta S. Bagheri N, et al. Prim Care. 2015 Sep;42(3):347-61. doi: 10.1016/j.pop.2015.05.010. Prim Care. 2015. PMID: 26319342 Review.
Retinal Vascular Occlusion and Underlying Generalized Vascular Diseases.
Feltgen N, Agostini H. Feltgen N, et al. Klin Monbl Augenheilkd. 2023 Sep;240(9):1071-1076. doi: 10.1055/a-2097-0938. Epub 2023 May 22. Klin Monbl Augenheilkd. 2023. PMID: 37216967 English, German.
Retinal vascular occlusion not only threatens vision loss but is also associated with other systemic risk factors and vascular diseases. ...Every new diagnosed retinal vascular occlusion should therefore be taken as an occasion to search …
Retinal vascular occlusion not only threatens vision loss but is also associated with other systemic risk factors and v …
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema.
Wykoff CC, Garweg JG, Regillo C, Souied E, Wolf S, Dhoot DS, Agostini HT, Chang A, Laude A, Wachtlin J, Kovacic L, Wang L, Wang Y, Bouillaud E, Brown DM. Wykoff CC, et al. Am J Ophthalmol. 2024 Apr;260:70-83. doi: 10.1016/j.ajo.2023.07.012. Epub 2023 Jul 15. Am J Ophthalmol. 2024. PMID: 37460036 Free article. Clinical Trial.
Intraocular inflammation rates for BRO6 vs AFL were 4.2% vs 1.1% (KESTREL) and 2.2% vs 1.7% (KITE), of which retinal vasculitis rates were 0.5% vs 0% in KESTREL, with no cases in KITE. Retinal vascular occlusion rates were 1.6% vs 0.5% (KESTREL) and 0.6% in b …
Intraocular inflammation rates for BRO6 vs AFL were 4.2% vs 1.1% (KESTREL) and 2.2% vs 1.7% (KITE), of which retinal vasculitis rates were 0 …
Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
Zheng C, Lin Y, Jiang B, Zhu X, Lin Q, Luo W, Tang M, Xie L. Zheng C, et al. Front Endocrinol (Lausanne). 2022 Oct 10;13:954453. doi: 10.3389/fendo.2022.954453. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36299452 Free PMC article.
The causal effects of plasma lipid levels and the risk of retinal vascular occlusion (RVO) have not been clearly identified, especially for high-density lipoprotein-cholesterol (HDL-C) and low-density lipoprotein-cholesterol (LDL-C). ...
The causal effects of plasma lipid levels and the risk of retinal vascular occlusion (RVO) have not been clearly identi …
Retinal vascular occlusion risks during the COVID-19 pandemic and after SARS-CoV-2 infection.
Park HS, Kim S, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ. Park HS, et al. Sci Rep. 2023 Oct 6;13(1):16851. doi: 10.1038/s41598-023-44199-z. Sci Rep. 2023. PMID: 37803163 Free PMC article.
However, evidence on the causal relationship between COVID-19 infection and retinal vascular occlusions remains limited. This study aimed to determine the change in retinal vascular occlusion incidence during COVID-19 era and whether severe acute respiratory …
However, evidence on the causal relationship between COVID-19 infection and retinal vascular occlusions remains limited. This study aimed to …
149 results